A vaccine that is under clinical study in Greece appears to put a halt to breast cancer metastasis and recurrence, according to the first results of a study completed in the US.
The vaccination is designed to preven cancer from recurring in women who have concluded their classic therapy (surgery, chemotherapy, radiation) and are free of the disease.
The vaccine does not cause any side-effects contrary to classic therapy.